INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endava plc

Endava placed CFO Mark Thurston on administrative leave while independent outside counsel investigates the accounting treatment of certain customer and supplier agreements. The disclosure drove Endava ADRs down $0.68, or 24.37%, to $2.11 on September 22. Pomerantz LLP is investigating potential securities-fraud and other unlawful-business-practice claims on behalf of investors.

Analysis

The relevant investable issue is not litigation headline risk but the probability that the underlying review changes reported revenue, gross margin, working capital, or customer concentration disclosures. At a distressed equity price, a modest restatement can still be highly dilutive if it triggers covenant pressure, delayed filings, auditor qualification, or a need to rebuild finance leadership; the ADR’s low nominal price also raises reverse-split and listing-compliance risk. Until management quantifies affected contracts and periods, the equity should be valued as an option on the investigation outcome rather than on normalized IT-services earnings.

Near term (days to weeks), borrow availability and liquidity are likely to dominate fundamentals: class-action announcements themselves add little incremental liability information, but can reinforce retail selling and deter prospective clients or employees. The more consequential 1-3 month catalysts are filing delays, auditor communications, a preliminary estimate of any correction, customer-contract renewal commentary, and whether the board expands the review beyond the initially identified arrangements. A clean conclusion with immaterial adjustments could produce a sharp short-covering rally from depressed levels; a restatement or delayed annual report would likely compress the remaining equity value further.

The contrarian case is that accounting classification issues in customer/supplier arrangements may be timing or gross-versus-net matters rather than cash leakage, making the selloff larger than the ultimate economic damage. That case is not actionable without evidence that operating cash flow, receivables collections, and contract renewals remain intact. Larger digital-engineering peers EPAM and GLOB are only indirect relative beneficiaries: disruption at DAVA can improve hiring and account-win opportunities, but no material earnings read-through should be assumed absent disclosed client transfers.

Key Decisions for Investors

• Maintain DAVA as avoid/no-long pending quantified scope of the review; do not treat the law-firm investigation as an independent catalyst. Reassess only after an independent-counsel update and confirmation of filing timing.
• For existing long exposure, reduce rather than average down over the next 1-3 months; retain only a small event-risk position sized as potentially zero-equity-value capital. A delayed filing, auditor resignation, restatement, or evidence of receivables impairment falsifies any recovery thesis.
• For tactical bearish exposure, prefer a defined-risk put spread or small short only after confirming borrow cost and locate stability; downside is constrained by the low share price while a clean-review announcement can drive an outsized percentage squeeze. Cover on a formal finding of immaterial adjustments plus reaffirmed cash-flow guidance.
• Place a watch alert on operating cash flow versus EBITDA, days sales outstanding, net cash/debt, and disclosed affected-contract value at the next update. Evidence that cash conversion and customer retention are unaffected would support a high-volatility rebound trade; missing data means no conviction long yet.
• Do not initiate EPAM/GLOB longs solely as sympathy beneficiaries. Consider them only if subsequent disclosures identify client churn or delivery disruption that creates verifiable share-transfer opportunities over the next 6-18 months.